San Francisco, CA, United States of America

Sara Pagans Lista


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2011-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sara Pagans Lista

Introduction

Sara Pagans Lista is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biomedical research, particularly in the area of HIV treatment. With a total of two patents to her name, her work focuses on innovative methods for identifying and treating immunodeficiency virus infections.

Latest Patents

Sara's latest patents include a screening method for the identification of inhibitors of HIV Tat methylation by the lysine methyltransferase Set7/9. This invention provides isolated methylated Tat peptides and compositions comprising these peptides. Additionally, it offers isolated antibodies specific for a Lys-51-methylated Tat polypeptide. The patent also outlines methods for identifying agents that inhibit Lys-51 methylation of a Tat polypeptide, as well as methods for treating an immunodeficiency virus infection in a mammalian subject. Another patent focuses on methylated Tat polypeptides and methods of use thereof, further emphasizing her commitment to advancing HIV research.

Career Highlights

Sara Pagans Lista is affiliated with the J. David Gladstone Institutes, where she conducts her research. Her work has garnered attention for its potential impact on HIV treatment and prevention. She is dedicated to exploring innovative solutions to complex biomedical challenges.

Collaborations

Sara collaborates with Melanie Ott, a fellow researcher at the J. David Gladstone Institutes. Together, they work on advancing the understanding of HIV and developing new therapeutic strategies.

Conclusion

Sara Pagans Lista's contributions to HIV research through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in the treatment of immunodeficiency virus infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…